344 results about "Selaginella tamariscina" patented technology

The invention provides a cosmetic composition containing a TCM (traditional Chinese medicine) extracting solution. The TCM extracting solution is composed of the following Chinese herbal medicines in parts by weight: ginseng, angelica sinensis, snow lotus herbs, folium artemisiae argyi, panax notoginseng, olibanum, fortune eupatorium herbs, radix pseudostellariae, agrimonia pilosa ledeb, radix polygonati officinalis, corn cervi pantotrichum, radix gentianae, flos magnolia, selaginella tamariscina, peony, Chinese herbaceous peony, herba centellae, pogostemon cablin, rhizoma ligustici wallichii, poria cocos, radix aucklandiae, anthemis tinctoria, and fructus lycii. The invention also provides a preparation method of the cosmetic composition containing a TCM extracting solution. The cosmetic composition disclosed by the invention is a cosmetic product which is implemented by the collaborative application of multiple TCM skin care products, and is good in extraction effect and high in quality, and each product reaches the international standards.

The invention provides a Chinese medicine composition for improving the egg laying performance of laying hens. The Chinese medicine composition is characterized by comprising epimedium, malt, madder, antifebrile dichroa, hedyotis diffusa, acanthopanax root, twotooth achyranthes root, vietnamese sophora root, prepared rehmannia root, tuber fleeceflower stem, flatstem milkvetch seed, Morinda officinalis, liriope spicata, adenophora tetraphylla, illicium verum, Persimmon Calyx, Chinese radish seed, selaginella tamariscina, stigma croci and sealwort. The feed provided by the invention can be used for ensuring the pure naturalness while improving the egg laying performance of laying hens, is free of disease resistance and small in toxic and side effects and has less damage to a human body.

The invention discloses a traditional Chinese medicine composition with whitening and anti-aging effects and a preparation method and application of an extract thereof. The traditional Chinese medicine composition disclosed by the invention is prepared from the following ingredients in percentage by weight: 1-30% of radix asparagi, 1-30% of evening primrose, 3-50% of chaenomeles lagenaria, 3-50% of pomegranate peel, 1-30% of giant knotweed rhizome, 3-40% of herba selaginellae, 2-30% of cynomorium songaricum and 2-40% of oldenlandia diffusa. The extract of the traditional Chinese medicine composition disclosed by the invention plays roles in inhibiting melanocytes, inhibiting tyrosinase and resisting free radicals and ultraviolet rays, can be used for effectively inhibiting the generation of skin melanin, and has excellent whitening and anti-aging effects. The composition does not contain chemically-synthesized substances, is free from toxic or side effects, is low in skin irritation and stable in nature, and is safe and reliable.

S. pvlvinata (Hook.et Gev.) Maxim of Selaginella of Selaginellaceae, S. tamariscina (beav.) spring, S. moellendorfii Hieron and so on are taken as raw materials for extraction and separation of total flavonoids of the Selaginella and the single component amentoflavone thereof, thus preparing a pharmaceutical preparation for prevention and treatment for Alzheimer disease.

The invention provides a traditional Chinese medicine composition for curing tuberculous exadative pleurisy. The bulk drugs of the traditional Chinese medicine composition include flos farfarae, root bark of white mulberry, Chinese yam, euphorbia kansui, rhizoma panacis majoris, folium eriobotryae, radix stemonae, Chinese-date, inula flower, Chinese mahonia stems, rhizoma zingiberis, rhizoma sparganii, flowers carthami, folia perillae acutae, allium macrostemon, selaginella tamariscina, vine of multiflower knotweed, exocarpium, changium smyrnioides, poria cocos, semen coicis, turmeric, schisandra chinensis, semen lepidii, radix polygonati officinalis, rhizoma anemarrhenae, dayflower, polygonum cuspidatum, adenophora tetraphylla and kaladana. The traditional Chinese medicine composition reduces untoward effect of hydrothorax absorption, shortens course of disease, reduces pleural adhesions, pleural thickening and chest pain, enables hydrothorax absorption of patients to be quick, remarkably alleviates chest pain, and greatly reduces rate of pachynsis pleurae or pleural adhesion, thereby overcoming side effects caused by western drug therapy and having a certain curative effect on curing tuberculous exadative pleurisy.

The present invention provides a composition for treating cancers, which comprises (a) pharmaceutically acceptable carriers and (b) an effective amount of an aqueous or aqueous organic solvent extract of a crude preparation comprising Semen Trigonellae, Astragali Radix, Glehniae Radix, and Asparagi Radix. The preferred composition further comprises the extract of other anti-tumor medicinal materials, such as Fructus Ligustri Lucidi, or Herba Selaginellae Doederleinii. The present invention also provides the preparation method and use of the composition in treating cancers, especially lung cancers.

The invention discloses a pig growth promotion type green feed additive capable of replacing antibiotics and belongs to the field of feed additives. The additive consists of polygonatum odoratum polysaccharide, refined lotus root powder, chrysanthemum, pollen typhae, red dates, sophora fruit, ramulus mori, selaginella tamariscina, perilla leaf, blueberry, complex vitamins, composite amino acids and a carrier, wherein the carrier is wheat middling and zeolite powder. According to the additive, the pig growth performance can be effectively improved, the pig feed conversion ratio is reduced, the feed utilization rate is improved, the feeding value is increased, and the feed additive can replace applications of antibiotics in the feed and has wide application prospects.

The invention provides a Chinese herbal composition which comprises semen nigellae, eclipta, black beans, polygonum multiflorum, fructus psoraleae, crocus sativus, madder, woad, Chinese gall leaven, selaginella, salt, iron vitriol, lemon, water soluble beewax, safflower seed oil, rosemary essential oil, thyme essential oil, and peppermint essential oil. The Chinese herbal composition is paste prepared from the natural Chinese herbal raw materials, is non-irritant, has no toxic and side effect, and is fast and firmer in dying when being compared with the conventional plant hair dye. The method adopts a low-alcohol low-temperature hot-reflux traditional Chinese medicine extracting technology, so as to improve effective constituent dissolving out rate and promote transdermal absorption. The paste is lubricating, is convenient to smear and clean, can not only shield white hair, but also care and protect hair, and inhibit, delay and reduce generation of white hair. The Chinese herbal composition being paste is mainly used for hair dying and nourishing of white hair, yellow hair and other light-colored hair.

The invention relates to a preparation method for traditional Chinese medicine for treating heart blood stasis type palpitation, which belongs to the technical field of the traditional Chinese medicine preparation method. At present, the Western medicine is commonly used for treating the heart blood stasis type palpitation, thus side effect and adverse reaction are easy to cause. The technical scheme provided by the invention is that China rose, the root of red-rooted salvia, impatiens balsamina, leech, fruits of polygonum orientale, humifuse euphorbia herb, corydalis tuber, native copper, artemisia anomala, red flower, azalea, hematoxylon, spina gleditsiae, myrrh, caulis spatholobi, frankincense, herba lycopi, selaginella tamariscina, acronychia pedunculata, rhizoma polygoni paleacei, motherwort fruit, ramulus euonymi, turmeric, peach kernel, Chinese trumpet creeper, ginseng, Chinese date, wheat, dried Longan pulp, American ginseng, felicitous plant, egg yolk, maltose, holly leaf, lotus seed, dangshen, mulberry, astragalus mongholicus, ligusticum wallichii and liquorice serve as raw materials; the traditional Chinese medicines are dipped in water and decocted by slow fire to be subjected to filtering and slag removing; and the decocted liquid medicine is the traditional Chinese medicine for treating heart blood stasis type palpitation. The traditional Chinese medicine for treating heart blood stasis type palpitation has the advantages that the traditional Chinese medicine can be favorably absorbed in the digestive tract after being orally taken and has a stable curative effect, and the heart blood stasis type palpitation has small possibility of recurring.

The present invention relates to a medicine for treatment of skin ulcer. The medicine comprises, by weight, 5-15 parts of selaginella tamariscina, 3-8 parts of borneol, 10-20 of rheum officinale; 5-15 parts of litharge; 5-15 parts of catechu; 10-20 parts of crude fossil fragments; 10-20 parts of Chinese angelica; 3-8 parts of cinnabar; 5-15 parts of frankincense; 3-8 parts of dragon's blood; 4-12 parts of lithospermum; 6-14 parts of Chinese magnoliavine; and 10-16 parts of calamine. Traditional Chinese medicines of the invention are formulated by clinical combination for several times, The medicine has effects of invigorating blood circulation and dispelling slough, relieving pain and promoting regeneration, engendering flesh, astringing sore and solidifying skin, nourishing blood, moistening skin and dispelling turgescence. The medicine is based on systemic treatment, treats both principal and secondary aspect of disease after being used. Proved by hundreds of clinical experiments, the medicine has obvious effects for severe and lingering ulcer, complex wound (such as cutting, stamping contusion, open fracture, and the like), bedsore, lower limb ulcer, and the like. The effective rate achieves 92%. The medicine has high cure rate.

In the invention, methods such as ethyl alcohol extraction and polyamide column chromatography and the like are employed to prepare high content selaginella general flavone and high purity amentotaxus biflavone monomer ingredients in large quantity from S. pvlvinata (Hook. et Gev.) Maxim, S. tamariscina (beav.) spring and S. moellendorfii Hieron of Selaginella for the first time. The selaginella general flavone and the amentotaxus biflavone monomer ingredients are proven to have the function of myocardial ischemia resistance and the new usage of curing angiocardiopathy caused by myocardial ischemia and the like.

The invention relates to a medicine for in vitro hemostasis and a preparation method of the medicine. The in vitro injury bleeding conditions frequently occur in life; some in vitro injury bleeding conditions are caused by chance; some in vitro injury bleeding conditions are generated by combination with internal causes of the organism; the bleeding is caused by vascular permeability increase of postcapillary venule, capillary vessels and precapillary arteriole; blood leaks out of a lumen through an expanded endothelial cell clearance and a damaged vascular basement membrane, for example, finger injury bleeding, toe injury bleeding, skin scratch bleeding and the like. The medicine is prepared by combining the following raw materials: cirsium japonicum, cuttle bone, herba cirsii, cutch, sanguisorba officinalis, dragon blood, ramie root, loofah sponge, sophora japonica, rheum officinale, puffball, hairyvein agrimony, shrubalthea bark, rhizoma bletillae, alumen, crinis trachycarpi, coptis chinensis, folium artemisiae argyi, indigo naturalis, panax notoginseng, carbonized hair, pericarpium granati, cattail pollen, dark plum, ophicalcite, mongolian snake gourd roots, selaginella tamariscina, halloysitum rubrum, schizonepeta and cacumen biotae. The raw materials are combined to generate the synergistic effect in efficacy, so that in vitro injury bleeding can be effectively treated.

The invention provides a Chinese medicinal composition for treating idiopathic facial paralysis. The Chinese medicinal composition comprises cassia twig, great burdock achene, giant typhonium rhizome, earthworm, storax, tall gastrodia tuber, dangshen, acanthopanax root, lotus seed, cortex eucommiae, red-rooted salvia root, twotooth achyranthes root, Chinese mosla herb, sargentg loryvine stem, common jasminorange leaf and twig, peach kernel, geranium wilfordii, India mustard seed, Chinese angelica, tamariskoid spikemoss herb, benzoin, dried orange peel, dried ginger and liquoric root. The Chinese medicinal composition provided by the invention has the advantages of short treatment course, good curative effect and freeness from toxic and side effects in comparison to a Chinese medicine on the aspect of treatment of idiopathic facial paralysis.

The invention relates to high-content S.tamariscina(beav.)spring total flavonoids and a high-purity amentotaxus argotaenia biflavone monomer composition firstly prepared from Selaginella S.pvlvinata(Hook.et Gev.)Maxim, S.tamariscina(beav.) spring and S.moellendorfii Hieron by a macroporous resin and polyamide serial columns in series chromatography method. The S.tamariscina(beav.)spring total flavonoids and the amentotaxus argotaenia biflavone monomer composition are firstly proved to have functions of inhibiting alpha-glucosaccharase, reducing blood sugar, and regulating blood fat, and the S.tamariscina(beav.)spring total flavonoids and amentotaxus argotaenia biflavone in preventing have new application in treating hyperglycemia and hyperlipemia.

The invention discloses a traditional Chinese medicine composition for treating allergic rhinitis, which is prepared from the following active pharmaceutical ingredients: radix astragali, rhizoma atractylodis macrocephalae, radix sileris, cocklebur fruit, magnolia flower, herba siegesbeckiae, cicada ecdysis, cornel, fructus psoraleae, lily root, dark plum, radix angelicae, notopterygium root, radix polygonati officinalis, roasted licorice, coix seed, chastetree fruit, Spica Schizonepetae, balloonflower, fructus aurantii, nidus vespae, Tribulus terrestris, Hyssopus officinalis, Ziziphora clinopodioides Lam, wild poppy, Manchurian Lilac, tuber pinellia, groundsel and herba selaginellae. The traditional Chinese medicine composition for treating allergic rhinitis has the effects of invigorating the spleen to benefit the lung, regulating ying and wei, invigorating qi and strengthening the body surface resistance, and is mainly used for treating allergic rhinitis caused by insufficiency of the lung-qi, spleen-qi and kidney-qi; the preparation technique is simple and convenient; and the traditional Chinese medicine composition for treating allergic rhinitis has the advantages of small toxic and side effects and low cost, and is convenient to take and easy to prepare. The traditional Chinese medicine composition can directly get to the focus, and has the advantages of short curing time and low recurrence tendency after curing.

The invention provides a traditional Chinese medicine preparation for treating immune thrombocytopenia (ITP) and a preparation method thereof. The traditional Chinese medicine preparation comprises the following components in parts by weight: 1 part of selaginella tamariscina, 1-2 parts of acanthopanax, 1-2 parts of morinda officinalis, 1-2 parts of dandelion, 1-2 parts of pseudo-ginseng, 1-2 parts of spatholobus stem, 1-2 parts of white peony root, 1-2 parts of angelica, 1-2 parts of bighead atractylodes rhizome, 1-2 parts of red sage root, 1-2 parts of radix rehmanniae, 1-2 parts of radix astragali, 1-2 parts of dangshen, 1-2 parts of agrimony and 1-2 parts of dodder. From the perspective of modern pharmacological research, the medicines contained by the traditional Chinese medicine preparation of the invention have the effects of regulating immunity, reducing platelet destruction, promoting thrombopoiesis, reducing capillary permeability and the like, thereby achieving the purpose of treating ITP. The medicines are compatible, the formula is simple and complete and hits the pathogenesis, and the medicines play the effects of removing pathogenic heat from blood, removing blood stasis, arresting bleeding, and reinforcing the spleen and kidney, thereby reducing hemorrhage of patients with ITP and alleviating various clinical symptoms.

The present invention relates to a new application of Chinese herbal medicine Herba Selaginellae Moellendorfii, its English name is Moellendorys Spikemoss Herb. Specially, it relates to its application in preparation of medicine for curing gastrophthy. Said invention also provides several Chinese medicine compositions using herba selaginellae moellendorfii as main medicine for curing gastropathy.

The invention discloses finelydivided phtheirospermum healthcare cured mutton and a processing method thereof. The finelydivided phtheirospermum healthcare cured mutton is prepared from the following raw materials in parts by weight: 80-100 parts of fresh mutton, 5-8 parts of finelydivided phtheirospermum, 1-3 parts of gynostemma pentaphylla, 2-3 parts of calendula, 2-4 parts of sanchi flower, 2-3 parts of glossy ganoderma, 2-3 parts of day lily flowers , 2-3 parts of euphorbia humifusa, 1-3 parts of selaginella, 1-4 parts of trumpet creeper, 6-8 parts of apple juice, 6-8 parts of pineapple juice, 8-10 parts of table salt and 6-8 parts of nutritional additive. According to the processing method, the finelydivided phtheirospermum healthcare cured mutton is prepared by processing, curing and airing the fresh mutton which is used as the main raw material and is matched with the finelydivided phtheirospermum and multiple traditional Chinese herb components. The finelydivided phtheirospermum healthcare cured mutton obtained by the processing method has the healthcare effects of dispelling cold and tonifying kidney and the characteristics of golden yellow color and luster, aromatic flavor, fat but not greasy, durable storage and the like.

The invention discloses a traditional Chinese medicine composite for treating immune thrombocytopenic purpura. The traditional Chinese medicine composite is prepared from the following raw materials in parts by weight: 10-30 parts of cornu bubali, 10-30 parts of indigo naturalis, 10-30 parts of lithospermum, 10-30 parts of pseudo-ginseng, 10-30 parts of selaginella tamariscina, 10-30 parts of angelica sinensis, 1-5 parts of ginseng, 10-30 parts of astragalus mongholicus, 10-30 parts of rehmannia root, 1-5 parts of antler slices, 10-30 parts of tortoise shell, 1-5 parts of placenta hominis, 10-15 parts of radix salviae miltiorrhizae, 10-30 parts of polygonum cuspidatum and 10-20 parts of cortex moutan. The traditional Chinese medicine composite is prepared into powder, pills, pastes or tablets by weighing the raw materials in the weight proportion and using a conventional traditional Chinese preparation method. The traditional Chinese medicine composite is high in components and is quantitatively blended; the dosage form can be powder, pills, pastes or tablets; and the medicines are matched with each other, the composite has the functions of replenishing qi to invigorate the spleen, governing the blood, tonifying kidney to perform spermatogenesis and culture the blood, promoting blood circulation to remove blood stasis to generate new blood, so that the human immunocompetence can be obviously improved, the micro-circulation is improved, the blood cells are increased, and the worries and the poor reaction of the patients caused by hormonotherapy of western medicine and spleen cutting are improved.

The invention discloses a compound anesthetic. The compound anesthetic is prepared from the following medicine materials by weight: 5g of keel, 5g of spina date seed , 4g of cortex albiziae, 4g of tsinling larkspur root, 5g of kamuning, 1g of acutangular anisodus root, 4g of radix aconiti agrestis , 3g of mimosa pudica, 3g of cortex moutan, 10g of sungpan monkshood root, 5g of pericarpium papaveris, 6g of semen brassicae, 3g of honeysuckle, 4g of selaginella tamariscina and 5g of girald daphne bark. According to clinical experiments, the compound anesthetic disclosed by the invention can be used for achieving the compound effects of narcotizing and relieving pains by selecting proper traditional Chinese medicine agent and optimizing proportion thereof, and is safe and free of toxic and side effect.

The invention discloses an introduction and cultivation method of selaginella tamariscina, and belongs to the technical field of plant cultivation. The problems that existing wild selaginella tamariscina is low in introduction survival rate and improper in cultivation management are solved. The method comprises the steps that 1, large and middle stretching selaginella tamariscina plants with the bright green color and no residues are selected for collection from beginning of June to beginning of October each year in the northern area, and original soil and the underground portions of the plants are reserved and damage is avoided during collection; 2, the selaginella tamariscina plants with the original soil are transplanted into a potted culture medium within 3-5 d after collection is performed, the plants are placed at a greenhouse, the planting depth is controlled to be 10-15 cm, and thorough watering is performed one time on the planting day; 3, management and culture are performed after transplanting, wherein the shading rate is controlled to be 65-75%, the culture temperature is controlled to be 22-28 DEG C, the soil is kept wet slightly, and the moisture is controlled to be 70-80%. Collection can be performed all the year round in the southern area, and transplanting is performed within 7 days after collection is performed. The transplanting rate can reach 95% or above.

The invention relates to a traditional Chinese medicine composition for treating hysteromyoma. The composition is prepared from the following raw materials, by weight, 25-35 parts of safflowers, 25-35 parts of frankincense, 25-35 parts of myrrh, 15-25 parts of radix codonopsis, 10-20 parts of bighead atractylodes rhizome, 10-20 parts of achyranthes roots, 10-20 parts of salvia miltiorrhiza, 10-20 parts of tangerine seeds, 10-20 parts of subprostrate sophora, 10-20 parts of lychee seeds, 10-15 parts of seaweed, 10-15 parts of oyster, 10-15 parts of rhizoma sparganii, 10-15 parts of curcuma zedoary, 7-13 parts of cassia twig, 7-13 parts of poria cocos, 7-13 parts of peach seeds, 7-13 parts of tree peony bark, 7-13 parts of red paeony roots, 7-13 parts of turtle shells, 7-13 parts of selaginella tamariscina, 7-13 parts of green tangerine peel, 7-13 parts of teasel roots, 7-13 parts of radix astragali, 7-13 parts of phellodendron, 7-13 parts of edible tulip and 7-13 parts of cyperus rotundus. The traditional Chinese medicine composition has advantages of stable curative effects, short curative time and minimal side effects.

Guizhi Sanleng Xiaoliu Pill is a new technology for treating women's uterine fibroids. It solves the problem that uterine fibroids cannot be cured in the category of TCM syndromes. The formula: Guizhi 10g, Sanleng 10g, Poria 10g , 10g peach kernel, 10g paeonol, 10g white peony (red peony), 10g turtle shell, 10g selaginella, 10g mugwort leaf, 10g green skin, 10g chuanduan (dipsac), 10g astragalus, 30g oyster, 6g cork, wangbuliu 100g, Prunella vulgaris 30g, Perilla 30g, Codonopsis 30g, Pangolin 10g, Curcuma 10g, the pharmacological effects of the formula: relieve the exterior cold, warm the meridian and unblock the yang, relieve stagnation and stagnation, promote qi and relieve pain, clear heat and cool blood, purify fire and detoxify, activate blood powder Blood stasis, swelling and pus discharge, dispersing blood and dredging collaterals, softening and resolving hard masses, through the 10 cases cured by us, Guizhi Sanleng Xiaoliu Pill is the only effective new technology invented to treat uterine fibroids. This difficult problem that other drugs and surgical treatment cannot cure for a long time.